Complementary and alternative medications for women's health issues

Nutrition in Clinical Practice

Volumn 24, Issue 5, 2009, Pages 589-608

  Lloyd, Kimberly Braxton ^a   Hornsby, Lori B ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Complementary therapies; Dietary supplements; Dysmenorrhea; Female infertility; Hot flashes; Menopause; Pregnancy; Premenstrual syndrome (PMS); Vitamins; Women's health

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BENDECTIN; CALCIUM; FISH OIL; FLUOXETINE; IBUPROFEN; MAGNESIUM; MASTODYNON; MINERAL; OMEGA 3 FATTY ACID; PHYTOESTROGEN; PLACEBO; PRIMROSE OIL; PYRIDOXINE; THIAMINE; VITAMIN; VITEX AGNUS CASTUS EXTRACT;

ALTERNATIVE MEDICINE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIARRHEA; DIET SUPPLEMENTATION; DRUG WITHDRAWAL; DYSMENORRHEA; DYSPEPSIA; EVIDENCE BASED MEDICINE; FEMALE; FEMALE INFERTILITY; GASTROINTESTINAL SYMPTOM; GINGER; HOT FLUSH; HUMAN; HYPEREMESIS GRAVIDARUM; MENOPAUSAL SYNDROME; NAUSEA; PREMENSTRUAL SYNDROME; REVIEW; VITAMIN SUPPLEMENTATION;

COMPLEMENTARY THERAPIES; DIETARY SUPPLEMENTS; DYSMENORRHEA; FEMALE; HERBAL MEDICINE; HOT FLASHES; HUMANS; INFERTILITY, FEMALE; MENOPAUSE; PHYTOTHERAPY; PLANTS, MEDICINAL; PREGNANCY; PREMENSTRUAL SYNDROME; WOMEN'S HEALTH;

EID: 74549159708     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0884533609343001     Document Type: Review

References (110)

1. Dennehy C. The use of herbs and dietary supplements in gynecology: an evidence-based review. J Midwifery Womens Health. 2006;51:402-409.
2. Eisenberg DM, Davis RB, Ettner S, et al. Trends in alternative medicine use in the United States, 1990-1997. JAMA. 1998; 280:1569-1575.
3. Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med. 2002;137:805-813.
4. Proctor M, Farquhar C. Diagnosis and management of dysmenorrhoea. BMJ. 2006;332:1134-1138.
5. French L. Dysmenorrhea. Am Fam Physician. 2005;71:285-291.
6. Rosenwaks Z, Seegr-Jones G. Menstrual pain: its origin and pathogenesis. J Reprod Med. 1980;25(suppl 4):207-212.
7. Proctor M, Murphy PA. Herbal and dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev. 2001;2:CD002124.
8. Sanfilippo J, Erb T. Evaluation and management of dysmenorrhea in adolescents. Clin Obstet Gynecol. 2008;51:257-267.
9. Gokhale L. Curative treatment of primary (spasmodic) dysmenorrhoea. Indian J Med Res. 1996;103:227-231.
10. Dawood M. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol. 2006;108:438-441.
11. Ziaei S, Faghihzadeh S, Sohrabvand F, Lamyian M, Emamgholy T. A randomized placebo-controlled trial to determine the effect of vitamin E in treatment of primary dysmenorrhoea. BJOG. 2001;108:1181-1183.
12. Ziaei S, Zakeri M, Kazemnejad A. A randomized controlled trial of vitamin E in the treatment of primary dysmenorrhoea. BJOG. 2005;122:466-469.
13. Vitamin E page. Natural Medicines Comprehensive Database [AUHSOP Intranet]. Stockton, CA: Therapeutic Research Faculty. Available at: http://www.naturaldatabase.com/(S(f0xm3o45bzpzryuboglsxz45))/nd/Search.aspx?cs= &s=ND&pt=100&id=954&ds=&name=VITAMIN+E. Accessed March 19, 2009.
14. Deutch B. Menstrual pain in Danish women correlated with low n-3 polyunsaturated fatty acid intake. Eur J Clin Nutr. 1995;49: 508-516.
15. Harel Z, Biro F, Kottenhahn R, Rosenthal S. Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrheal in adolescents. Am J Obstet Gynecol. 1996;174: 1335-1338.
16. Fish oil page. Natural Medicines Comprehensive Database [AUHSOP Intranet]. Stockton, CA: Therapeutic Research Faculty. Available at: http://www.naturaldatabase.com/(S(f0xm3o45bzpzryuboglsxz45))/nd/Search.aspx?cs= &s=ND&pt=100&id=993&ds=&name=FISH+OIL. Accessed March 19, 2009.
17. ACOG Committee Opinion. Premenstrual syndrome: Committee on gynecologic practice. Int J Gynaecol Obstet. 1995;50:80-84.
18. Girman A, Lee R, Kligler B. An integrative medicine approach to premenstrual syndrome. Clin J Womens Health. 2003;2:116-127.
19. Jarvis C, Lynch A, Morin A. Management strategies for premenstrual syndrome/premenstrual dysphoric disorder. Ann Pharmacother. 2008;42:967-978.
20. Thys-Jacobs S, Alvir MA. Calcium-regulating hormones across the menstrual cycle: evidence of secondary hyperparathyroidism in women with PMS. J Clin Endocrinol Metab. 1995;80:2227-2232.
21. Thys-Jacobs S, Ceccarelli S, Bierman A, Weisman H, Cohen M, Alvir J. Calcium supplementation in premenstrual syndrome: a randomized crossover trial. J Gen Intern Med. 1989;4:183-189.
22. Penland J, Johnson P. Dietary calcium and manganese effects on menstrual cycle symptoms. Am J Obstet Gynecol. 1993;168: 1417-1423.
23. Thys-Jacobs S, Starkey P, Bernstein D, Tian J. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Am J Obstet Gynecol. 1998;179:444-452.
24. 6 page. Natural Medicines Comprehensive Database [AUHSOP Intranet]. Stockton, CA: Therapeutic Research Faculty. Available at: http://www.naturaldatabase.com/(S(f0xm3o45bzpzryuboglsxz45))/nd/Search.aspx?cs= &s=ND&pt=100&id=934&ds=&name= Vitamin+B6+(PYRIDOXINE+(VITAMIN+B6)). Accessed March 19, 2009.
25. Barr W. Pyridoxine supplements in the premenstrual syndrome. Practitioner. 1984;228:425-427.
26. Williams M, Harris R, Dean B. Controlled trial of pyridoxine in the premenstrual syndrome. J Int Med Res. 1985;13:174-179.
27. Kendall K, Schnurr P. The effects of vitamin B6 supplementation on premenstrual symptoms. Obstet Gynecol. 1987;70:145-149.
28. Doll H, Brown S, Thurston A, Vessey M. Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial. J R Coll Gen Pract. 1989;39:364-368.
29. Smallwood J, Ah-Kye D, Taylor I. Vitamin B6 in the treatment of pre-menstrual mastalgia. Br J Clin Pract. 1986;40:532-533.
30. Wyatt K, Dimmock P, Jones P, O'Brian PM. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ. 1999;318:1375-1381.
31. Bendich A, Cohen M. Vitamin B6 safety issues. Ann N Y Acad Sci. 1990;585:321-330.
32. Cohen M, Bendich A. Safety of pyridoxine: a review of human and animal studies. Toxicol Lett. 1986;34:129-139.
33. Facchinetti F, Borella P, Fioroni L, Pironti T, Genazzani AR. Reduction of monocyte magnesium in patients affected by premenstrual syndrome. J Psychosom Obstet Gynaecol. 1990;11:221-229.
34. Rosenstein D, Elin R, Hosseini J, Grover G, Rubinow D. Magnesium measures across the menstrual cycle in premenstrual syndrome. Biol Psychiatry. 1994;35:557-561.
35. Facchinetti F, Borella P, Sances G, Fioroini L, Nappi R, Genazzani A. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol. 1991;78:177-181.
36. Walker A, DeSouza M, Vickers M, Abeyasekera S, Collins M, Trinca L. Magnesium supplementation alleviates premenstrual symptoms of fluid retention. J Womens Health. 1998;7:1157-1165.
37. DeSouza M, Walker A, Robinson P, Bolland K. A synergistic effect of daily supplement for 1 month of 200mg magnesium plus 50mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study. J Womens Health (Larchmt). 2000;9:131-139.
38. Shaw S, Wyatt K, Campbell J, Ernet E, Thompson-Coon J. Vitex angnus castus for premenstrual syndrome. Cochrane Database Syst Rev. 2003;4:CD004632.
39. Lauritzen CH, Reuter H, Repges R, Bohnert K, Schmidt U. Treatment of premenstrual tension syndrome with Vitex agnus castus: controlled, double-blind study versus pyridoxine. Phytomedicine. 1997;4:183-189.
40. Atmaca M, Kumru S, Tezcan E. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder. Hum Psychopharmacology Clin Exp. 2003;18:191-195.
41. Berger D, Schaffner W, Schrader E, Meier B. Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS). Arch Gynecol Obstet. 2000;264:150-153.
42. Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomized, placebo controlled study. BMJ. 2001;322:134-137.
43. Wang W, Chen HS, Liu JP. Evening primrose oil or other essential fatty acids for the treatment of pre-menstrual syndrome (PMS). Cochrane Database Syst Rev. 2008;2:CD001123.
44. Budeiri D, Li Wan Po A, Dornan JC. Is evening primrose oil of value in the treatment of premenstrual syndrome? Control Clin Trials. 1996;17:60-68.
45. Collins A, Cerin A, Coleman G, Landgren BM. Essential fatty acids in the treatment of premenstrual syndrome. Obstet Gynecol. 1993;81:93-98.
46. Puolakka J, Makarainen L, Viinikka L, Ylikorkala O. Biochemical and clinical effects of treating the premenstrual syndrome with prostaglandin synthesis precursors. J Reprod Med. 1985;30:149-153.
47. Infertility page. Natural Medicines Comprehensive Database [AUHSOP Intranet]. Stockton, CA: Therapeutic Research Faculty. Available at: http://www.naturaldatabase.com/(S(zz4pgh45ofjocz55saej4o55))/nd/Search.aspx?cs= &s=ND&pt=&sh=2&fs=ND&id=760&r=2&searchid= 14003326&txt=infertility#selected. Accessed March 12, 2009.
48. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2005;3:1-21.
49. Luck MR, Jeyaseelan I, Scholes RA. Ascorbic acid and fertility. Biol Reprod. 1995;52:262-266.
50. Henmi H, Endo T, Kitajima Y, Manase K, Hata H, Kudo R. Effects of ascorbic acid supplementation on serum progesterone levels in patients with a luteal phase defect. Fertil Steril. 2003;80: 459-461.
51. Crha I, Hruba D, Ventruba P, Fiala J, Totusek J, Visnova H. Ascorbic acid and infertility treatment [abstract]. Cent Eur J Public Health. 2003;11:63-67.
52. Griesinger G, Franke K, Kinast C, et al. Ascorbic acid supplement during luteal phase in IVF. J Assist Reprod Genet. 2002;19:164-168.
53. Roemheld-Hamm B. Chasteberry. Am Fam Physician. 2005; 72:821-824.
54. Gerhard II, Patek A, Monga B, Blank A, Gorkow C. Matodynon® for female sterility [abstract in English]. Forsch Komplementarmed. 1998;5:272-278.
55. Milewicz A, Gejdel E, Sworen H, et al. Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia: results of a randomized placebo-controlled doubleblind study [abstract in English]. Arzneimittelforschung. 1993;43: 752-756.
56. Westphal LM, Polan ML, Trant AS, Mooney SB. A nutritional supplement for improving fertility in women: a pilot study. J Reprod Med. 2004;49:289-293.
57. Westphal LM, Polan ML, Trant AS. Double-blind, placebo-controlled study of FertilityBlend: a nutritional supplement for improving fertility in women. Clin Exp Obstet Gynecol. 2006;33:205-208.
58. Gadsby R, Barnie-Adshead AM, Jagger C. A prospective study of nausea and vomiting during pregnancy. Br J Gen Pract. 1993;43: 245-248.
59. Lacroix R, Eason E, Melzack R. Nausea and vomiting during pregnancy: a prospective study of its frequency, intensity and patterns of change. Am J Obstet Gynecol. 2000;182:931-937.
60. Mazzotta P, Stewart D, Atanackovic G, Koren G, Magee L. Psychosocial morbidity among women with nausea and vomiting of pregnancy: prevalence and association with anti-emetic therapy. J Psychosom Obstet Gynaecol. 2000;21:129-136.
61. Badell M, Ramin S, Smith J. Treatment options for nausea and vomiting during pregnancy. Pharmacotherapy. 2006;26:1273-1287.
62. Ornstein M, Einarson A, Koren G. Bendectin/Diclectin for morning sickness: a Canadian follow-up of an American tragedy. Reprod Toxicol. 1995;9:1-6.
63. Kutcher J, Engle A, Firth J, Lamm S. Bendectin and birth defects II: ecological analyses. Birth Defects Res A Clin Mol Teratol. 2003;67:88-97.
64. Korcok M. The Bendectin debate. CMAJ. 1980;123:922-928.
65. Schuster K, Bailey LB, Dimperio D, Mahan CS. Morning sickness and vitamin B6 status of pregnant women. Hum Nutr Clin Nutr. 1985;39:75-79.
66. Sahakian V, Rouse D, Sipes S, Rose N, Niebyl J. Vitamin B6 is effective therapy for nausea and vomiting of pregnancy: a randomized, double-blind placebo-controlled study. Obstet Gynecol. 1991;78:33-36.
67. Vutyavanic T, Wongtra-ngan S, Ruangsri R. Pyridoxine for nausea and vomiting of pregnancy: a randomized, double-blind, placebocontrolled trial. Am J Obstet Gynecol. 1995;173:881-884.
68. Jewel D, Young G. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 2003;4:CD000145.
69. Nelson MM, Forfar JO. Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. Br Med J. 1971;1:523-527.
70. Shrim A, Boskovic R, Maltepe C, Navios Y, Garcia-Bournissen F, Koren G. Pregnancy outcome following use of large doses of vitamin B6 in the first trimester. J Obstet Gynecol. 2006;26:749-751.
71. Ginger page. Natural Medicines Comprehensive Database [AUHSOP Intranet]. Stockton, CA: Therapeutic Research Faculty. Available at: http://www. naturaldatabase.com/(S(f0xm3o45 bzpzryuboglsxz45))/nd/Search.aspx?cs=&s= ND&pt=100&id=961&ds=&name=GINGER. Accessed March 19, 2009.
72. Vutyavanich T, Kraisarin T, Ruangsri RA. Ginger for nausea and vomiting in pregnancy: randomized, double-masked, placebocontrolled trial. Obstet Gynecol. 2001;97:577-582.
73. Willetts K, Ekangaki A, Eden J. Effect of a ginger extract on pregnancy- induced nausea: a randomized controlled trial. Aust N Z J Obstet Gynaecol. 2003;43:139-144.
74. Tiran D. Nausea and vomiting in pregnancy: safety and efficacy of self-administered complementary therapies. Complement Ther Nurs Midwifery. 2002;8:191-196.
75. Portnoi G, Chng LA, Karimi-Tabesh L, Koren G, Tan M, Einarson A. Prospective comparative study of the safety and effectiveness of ginger for the treatment of nausea and vomiting in pregnancy. Am J Obstet Gynecol. 2003;189:1374-1377.
76. Smith C, Crowther C, Willson K, Hotham N, McMillian V. A randomized controlled trial of ginger to treat nausea and vomiting in pregnancy. Obstet Gynecol. 2004;103:639-645.
77. Sripramote M, Lekhyananda N. A randomized comparison of ginger and vitamin B6 in the treatment of nausea and vomiting of pregnancy. J Med Assoc Thai. 2003;86:846-853.
78. Chittumma P, Kaewkiattikun K, Wiriyasiriwach B. Comparison of the effectiveness of ginger and vitamin B6 for treatment of nausea and vomiting in early pregnancy: a randomized double-blind controlled trial. J Med Assoc Thai. 2007;90:15-20.
79. Ensiyeh J, Sakineh MA. Comparing ginger and vitamin B6 for the treatment of nausea and vomiting in pregnancy: a randomised controlled trial. Midwifery. In press.
80. North American Menopause Society. Treatment of menopauseassociated vasomotor symptoms: position statement of the North American Menopause Society. Menopause. 2004;11:11-33.
81. Utian WH, Archer DF, Bachmann GA, et al. Estrogen and progesterone use in postmenopausal women: July 2008 position statement of the North American Menopause Society. Menopause. 2008;15(4 pt 1):584-602.
82. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA. 2002;288: 321-333.
83. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA. 2004;291:47-53.
84. Krebs EE, Ensrud KE, MacDonald R, Wilt TJ. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol. 2004;104:824-836.
85. Huntley AL, Ernst E. Soy for the treatment of perimenopausal symptoms: a systematic review. Maturitas. 2004;47:1-9.
86. Knight DC, Eden JA. A review of the clinical effects of phytoestrogens. Obstet Gynecol. 1996;87:897-904.
87. Nelson HD, Vesco KK, Haney E, et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA. 2006;295:2057-2071.
88. Lethaby A, Marjoribanks J, Kronenberg F, Roberts H, Eden J, Brown J. Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database Syst Rev. 2007;4:CD001395.
89. Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltnan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo. Ann Intern Med. 2006;145:869-879.
90. MacGregor CA, Canney PA, Patterson G, McDonald R, Paul J. A randomised double blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancer. Eur J Cancer. 2005;41:708-714.
91. Zhang X, Shu X-O, Li H, et al. Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women. Arch Intern Med. 2005;165:1890-1895.
92. Ma DF, Qin LQ, Wang PY, Katoh R. Soy isoflavone intake inhibits bone resorption and stimulates bone formation in menopausal women: meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2008;62:155-161.
93. Ma DF, Qin LQ, Wang PY, Katoh R. Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials. Clin Nutr. 2008;27:57-64.
94. Hooper L, Kroon PA, Rimm EB, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008;88:38-50.
95. Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M. Soy protein, isoflavones, and cardiovascular health: an American Heart Association science advisory for professionals from the nutrition committee. Circulation. 2006;113:1034-1044. (Pubitemid 43879479)
96. Manonai J, Songchitsomboon S, Chanda K, Hong JH, Komindr S. The effect of a soy-rich diet on urogenital atrophy: a randomized, cross-over trial. Maturitas. 2006;54:135-140.
97. Soy isoflavones page. Natural Medicines Comprehensive Database [AUHSOP Intranet]. Stockton, CA: Therapeutic Research Faculty. Available at: http://www.naturaldatabase.com/(S(34f2et45k45byya3fju4uvip))/nd/Search.aspx?cs= &s=ND&pt=&sh=20&fs=ND&searchid=13983017. Accessed March 12, 2009.
98. Mahady GB. Do soy isoflavones cause endometrial hyperplasia? Nutr Rev. 2005;63:392-397.
99. Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst. 2006;98:459-471.
100. Messina M, Redmond G. Effects of soy protein and soybean isoflavones on thyroid function in healthy adults and hypothyroid patients: a review of the relevant literature. Thyroid. 2006;16:249-259.
101. Borrelli F, Ernst E. Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy. Pharmacol Res. 2008;58:8-14.
102. Cheema D, Coomarasamy A, Toukhy TE. Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured, evidencebased review. Arch Gynecol Obstet. 2007;276:463-469.
103. Black cohosh page. Natural Medicines Comprehensive Database [AUHSOP Intranet]. Stockton, CA: Therapeutic Research Faculty. Available at: http://www.naturaldatabase.com/(S(xtxpmz3nl2yv2wz3wscclm45))/nd/Search.aspx?cs= &s=ND&pt=100&id=857&ds=dosage. Accessed March 12, 2009.
104. Jacobson JS, Troxel AB, Evans J, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol. 2001;19:2739-2745.
105. Stoll W. Phytopharmacon influences atrophic vaginal epithelium: double-blind study. Cimcifuga vs. estrogenic substances. Therapeuticum. 1987;1:23-31.
106. Briese V, Stammwitz U, Friede M, Henneicke-von Zepelin HH. Black cohosh with or without St. John's wort for symptom-specific climacteric treatment: results of a large-scale, controlled, observational study. Maturitas. 2007;57:405-414.
107. Borrelli F, Ernst E. Black cohosh (Cimicifuga racemosa): a systematic review of adverse effects. Am J Obstet Gynecol. 2008;199: 455-466.
108. Antoine C, Lievens F, Carly B, Pastijn A, Rozenberg S. Safety of alternative treatments for menopausal symptoms after breast cancer: a qualitative systematic review. Climacteric. 2007;10:23-26.
109. Ruhlen RL, Haubner J, Tracy JK, et al. Black cohosh does not exert an estrogenic effect on the breast. Nutr Cancer. 2007;59:269-277.
110. Walji R, Boon H, Guns E, Oneschuk D, Younus J. Black cohosh (Cimcifuga Racemosa [L.] Nutt.): safety and efficacy for cancer patients. Support Care Cancer. 2007;15:913-921.